Broncus Technologies, Inc. Release: Over 135 Patients Randomized in Airway Bypass Trial for Emphysema

MOUNTAIN VIEW, CA--(Marketwire - May 19, 2008) - Broncus Technologies, Inc., a medical device company that is investigating a stent-based procedure for the treatment of emphysema, announced today at the Annual Scientific Assembly of the American Thoracic Society (ATS), that over one hundred and thirty-five patients have been randomized in the EASE Trial for airway bypass. The EASE (Exhale Airway Stents for Emphysema) is a randomized, double-blind clinical trial to study the safety and effectiveness of the airway bypass procedure. This study is designed to include up to 450 patients around the world.